Other

Investments Fair Value Disclosure

Biogen Investments Fair Value Disclosure increased by 16.3% to $137.40M in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ4 2025
Last reportedQ1 2026
Metric ID: other_investments_fair_value_disclosure

Historical Data

2 periods
 Q4 '25Q1 '26
Value$118.10M$137.40M
QoQ Change—+16.3%
Range$118.10M – $137.40M

Investments Fair Value Disclosure at Other Companies

Roivant Sciences logo
Roivant SciencesROIVView metric

Frequently Asked Questions

What is Biogen's investments fair value disclosure?
Biogen (BIIB) reported investments fair value disclosure of $137.40M in Q1 2026.